SCHEMBL22930686

SCHEMBL22930686

c1ccc2c(c1)-c1ccccc1C21c2ccccc2C2(c3ccccc3-c3ccc4sc5ccccc5c4c32)c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
DUSP3 P51452 1/20 0.38
BLM P54132 1/20 0.38
PTPN5 P54829 1/20 0.38
PTPN11 Q06124 1/20 0.38
MCL1 Q07820 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
GPR3 P46089 1/20 0.38
HPGD P15428 2/20 0.32
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
BRDT Q58F21 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19760321 0.97 GPR3 (0.41) MAPTMEN1KMT2APOLBTDP1
SCHEMBL18732176 0.90 KDM4E (0.42) MAPTMEN1KMT2APOLBTDP1
SCHEMBL18732175 0.89 PDK2 (0.37) MAPTMEN1KMT2APOLBTDP1
SCHEMBL18732171 0.89 KDM4E (0.41) MAPTMEN1KMT2APOLBTDP1
SCHEMBL18732032 0.87 MEN1 (0.35) MAPTMEN1KMT2APOLBTDP1
SCHEMBL22930695 0.87 MEN1 (0.35) MAPTMEN1KMT2APOLBTDP1
SCHEMBL22182191 0.86 MAPT (0.35) MAPTMEN1KMT2APOLBTDP1
SCHEMBL20224560 0.85 PDK2 (0.38) MAPTMEN1KMT2APOLBTDP1
SCHEMBL19760331 0.85 PDK2 (0.38) MAPTMEN1KMT2APOLBTDP1
SCHEMBL15434193 0.85 MAPT (0.35) MAPTMEN1KMT2APOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10910567-B2 Double spiro-type compound and organic light emitting diode comprising same LG CHEM, LTD. 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910567-B2 Double spiro-type compound and organic light emitting diode comprising same NR2E3, ALDH1A2, CRY1 MAPT 1561/4885MEN1 1825/4885KMT2A 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.